Liver disease-related methods and systems

作者: Michael Becka , Guido Hennig , Mathias Gehrmann , Alastair D. Burt , Robert P. Thiel

DOI:

关键词:

摘要: The invention provides diagnostic methods, kits, and systems, related computer-readable media, which use multiple blood marker values, including serum plasma to aid in the diagnosis of status or progress a liver disease patient. also methods that values: (1) screen for active ingredients useful treatment disease; (2) selection regimens patients are predisposed to, suffer from, (3) design clinical programs monitoring one more patients.

参考文章(22)
Phillip Bukberg, Ira J. Goldberg, Disorders of Lipoprotein Metabolism Humana Press, Totowa, NJ. pp. 337- 348 ,(2002) , 10.1007/978-1-59259-277-7_19
Yasuteru Muragaki, Yasuo Bai, Eisaku Matsumoto, Kazushi Iwata, Akira Oshima, Satoshi Miyamoto, Method for determining human collagen peptides by way of enzyme immunoassay ,(1992)
Christophe Pilette, Marie Christine Rousselet, Pierre Bedossa, Daniel Chappard, Frédéric Oberti, Hervé Rifflet, Moussa Y. Maïga, Yves Gallois, Paul Calès, Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores: Comparison with serum markers Journal of Hepatology. ,vol. 28, pp. 439- 446 ,(1998) , 10.1016/S0168-8278(98)80318-8
Massimo Pinzani, Elmar-Reinhold Burchardt, Guido Hennig, Werner Kroll, Sylvia Unger, Alastair D. Burt, Michael Volker, Mathias Gehrmann, Andreas Knorr, Michael Becka, Michael J. Arthur, Detlef Schuppan, Assessment of liver fibrosis scoring with serum marker algorithms ,(2001)
G Castaldo, G Oriani, M M Lofrano, L Cimino, M Topa, G Budillon, F Salvatore, L Sacchetti, Differential diagnosis between hepatocellular carcinoma and cirrhosis through a discriminant function based on results for serum analytes. Clinical Chemistry. ,vol. 42, pp. 1263- 1269 ,(1996) , 10.1093/CLINCHEM/42.8.1263
Terence Chuen-Wai Poon, Anthony Tak-Cheung Chan, Benny Zee, Stephen King-Wah Ho, Tony Shu-Kam Mok, Thomas Wai-Tong Leung, Philip James Johnson, Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma. Oncology. ,vol. 61, pp. 275- 283 ,(2001) , 10.1159/000055334
Fedja A. Rochling, Evaluation of abnormal liver tests. Clinical Cornerstone. ,vol. 3, pp. 1- 12 ,(2001) , 10.1016/S1098-3597(01)90074-2